Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis

Energy metabolism in ALS: an underappreciated opportunity?

(2018) Tijs Vandoorne et al.   ACTA NEUROPATHOLOGICA

Disease-modifying effects of metabolic perturbations in ALS/FTLD

(2018) Ali Jawaid et al.   Molecular Neurodegeneration

The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis

(2017) F. D'Ovidio et al.   EUROPEAN JOURNAL OF NEUROLOGY

Psychiatric disorders prior to amyotrophic lateral sclerosis

(2016) Martin R. Turner et al.   ANNALS OF NEUROLOGY

Population-based risks for cancer in patients with ALS

(2016) Summer B. Gibson et al.   NEUROLOGY

Distribution of LDL subgroups in patients with hyperlipidemia

(2016) Ebru TAYLAN et al.   Turkish Journal Of Medical Sciences

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

(2016) Sabrina K. Hollinger et al.   Frontiers in Neurology

The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives

(2015) Parneet Kaur et al.   ACS Chemical Neuroscience

Association of alcohol use disorders with amyotrophic lateral sclerosis: a Swedish national cohort study

(2015) J. Ji et al.   EUROPEAN JOURNAL OF NEUROLOGY

Association between diabetes and amyotrophic lateral sclerosis in Sweden

(2015) D. Mariosa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study

(2015) Yu Sun et al.   JOURNAL OF EPIDEMIOLOGY

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis: Table 1

(2015) Martin R Turner et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Incidence, prevalence, and medical expenditures of classical amyotrophic lateral sclerosis in Taiwan, 1999–2008

(2015) Ching-Piao Tsai et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis

(2015) Sabrina Paganoni et al.   MUSCLE & NERVE

Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis

(2015) Cassie S. Mitchell et al.   Neurodegenerative Diseases

Angiotensin-Converting Enzyme Inhibitors and Amyotrophic Lateral Sclerosis Risk

(2015) Feng-Cheng Lin et al.   JAMA Neurology

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis

(2015) Marianthi-Anna Kioumourtzoglou et al.   JAMA Neurology

The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: A population-based prospective study

(2014) D. Michal Freedman et al.   INTERNATIONAL JOURNAL OF CANCER

Amyotrophic lateral sclerosis: new ideas from cancer

(2014) Giancarlo Logroscino et al.   LANCET NEUROLOGY

Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study

(2013) M. R. Turner et al.   NEUROLOGY

Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort

(2013) V. Gallo et al.   NEUROLOGY

Amyotrophic lateral sclerosis and vascular risk: a metabolic conundrum

(2011) O. Hardiman   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis

(2011) N. A. Sutedja et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

ALS disease onset may occur later in patients with pre-morbid diabetes mellitus

(2010) A. Jawaid et al.   EUROPEAN JOURNAL OF NEUROLOGY

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis

(2010) J. Dorst et al.   JOURNAL OF NEUROLOGY

Energy metabolism in amyotrophic lateral sclerosis

(2010) Luc Dupuis et al.   LANCET NEUROLOGY